Reply to Yager and Doll

Affiliations

¹ Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA.
² Influenza Division, Centers for Disease Control and Prevention, Atlanta Georgia, USA.

Comment

Manjusha Gaglani et al. Clin Infect Dis. 2020.

. 2020 Dec 15;71(12):3264-3265.

doi: 10.1093/cid/ciaa311.

¹ Baylor Scott and White Health, Texas A&M University College of Medicine, Temple, Texas, USA.
² Influenza Division, Centers for Disease Control and Prevention, Atlanta Georgia, USA.

No abstract available

Comment on

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
Gaglani M, Vasudevan A, Raiyani C, Murthy K, Chen W, Reis M, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Zimmerman RK, Nowalk MP, Monto AS, Martin ET, Chung JR, Spencer S, Fry AM, Flannery B. Gaglani M, et al. Clin Infect Dis. 2021 Apr 8;72(7):1147-1157. doi: 10.1093/cid/ciaa102. Clin Infect Dis. 2021. PMID: 32006430 Free PMC article.
Towards Understanding the Health and Economic Impacts of Quadrivalent and Trivalent Inactivated Vaccines Against Influenza B Infection: Additional Considerations for Future Cost-Benefit Analyses.
Yager EJ, Doll MK. Yager EJ, et al. Clin Infect Dis. 2020 Dec 15;71(12):3263-3264. doi: 10.1093/cid/ciaa309. Clin Infect Dis. 2020. PMID: 32202297 No abstract available.